Navigation Links
Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
Date:1/14/2009

ATLANTA, Jan. 14 /PRNewswire/ -- A patient who allegedly was seriously injured by Medtronic, Inc.'s Infuse(R) Bone Graft implant in an off-label surgical procedure promoted by Medtronic has sued the company, according to James A. Dunlap Jr. & Associates LLC and Page Perry, LLC.

The firms, along with co-counsel Lieff, Cabraser, Heimann & Bernstein, LLP, filed suit in New York federal court on behalf of Paul and Susan Antonelli, of Amsterdam, N.Y. The suit alleges that Mr. Antonelli was injured during a failed January 2006 procedure at a New York hospital to fuse vertebrae in his spine.

"The Antonelli family has suffered tremendously, and Mr. Antonelli remains in agonizing pain," said James A. Dunlap, one of the attorneys representing the Antonelli family. "Because of Medtronic's wrongful conduct, many other patients like Paul Antonelli may have improperly received Medtronic's Infuse(R) Bone Graft product for an off-label use."

The Complaint alleges, among other things, that Medtronic (NYSE: MDT) improperly promoted its Infuse(R) Bone Graft product for a cervical lumbar surgery procedure, when the product was not approved by the U.S. Food and Drug Administration for that use. Infuse(R) Bone Graft product may cause severe swelling in the neck and throat that restricts breathing and can lead to suffocation of the patient if used off-label for unapproved uses, particularly spinal surgery performed from the back.

The FDA has received more than 200 reports of significant side effects resulting from off-label use of the medical device, particularly in the cervical spine, a number of which have led to serious and potentially life-threatening complications.

The lawsuit alleges that Mr. Antonelli's post-operative period was marked by increasingly severe pain, selling of the neck, mental status changes, difficulty swallowing, and difficulty breathing during which he nearly suffocated. He then required an emergency bedside tracheotomy after a few of his front teeth were knocked out in an effort to intubate him.

Medtronic's Infuse(R) Bone Graft product has been the subject of a recent whistleblower lawsuit brought by former Medtronic employees who alleged that doctors received more than $8 million in 2006 in "sham" consulting fees for using and promoting the Infuse(R) Bone Graft product. Medtronic's marketing and promotion of the device for off-label uses is being investigated by the U.S. Department of Justice. In addition, the U.S. Senate is conducting hearings into the matter. Medtronic previously settled for $40 million with the Justice Department on another whistleblower action alleging that, between 1998 and 2003, Medtronic's spinal products division paid kickbacks to doctors in a number of forms, including sham consulting agreements, sham royalty agreements and lavish trips to desirable locations.

The case is "Paul and Susan Antonelli v. Medtronic, Inc. and Medtronic Sofamor Danek USA, Inc.," in the U.S. District Court, Southern District of New York (Case No. 09 CV 00183).

For additional information or to request a copy of the Complaint, contact James Dunlap, James A. Dunlap Jr. & Associates LLC at 404.354.2363, www.jamesdunlaplaw.com, or Page Perry, LLC, at 770.673.0047, www.pageperry.com.


'/>"/>
SOURCE James A. Dunlap Jr. & Associates LLC; Page Perry, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Medtronic, Inc. and Medtronic Sofamor Danek, USA, Inc. Sued for Product Liability and Promoting the Off-Label Use of Infuse(R) Bone Graft Product, According to Page Perry, LLC
2. U.S. District Court in Delaware Reinstates Damage Awards to Cordis Corporation on Patents Infringed by Medtronic, Inc. and Boston Scientific Corporation
3. Shareholder Class Action Filed Against Medtronic, Inc. by The Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
4. Supreme Court Hears Case on Federal Pre-emption of Safety Standards for Medical Technologies (Riegel v. Medtronic, Inc.)
5. Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc.
6. Court Rejects Two Medtronic Patents
7. NuVasive Announces Patent Infringement Complaint Brought by Medtronic Sofamor Danek
8. Medtronic Celebration of Courage Set for September 13th
9. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
10. Medtronic Mediterranean Launches Worlds First Arabic-Language Integrated Insulin Therapy for Improved Diabetes Management
11. Wolf Popper Announces Filing of Securities Class Action Lawsuit Against Medtronic Inc. - MDT
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... 2017 , ... “Emotions are sacred, valid, honored, encouraged. This is the memo ... Generation Mindful. To help change the mindset of parents and educators from punitive to ... the Time-In Toolkit, which launched on Kickstarter 3 weeks ago and fully funded in ...
(Date:8/18/2017)... ... August 18, 2017 , ... Alcovit, a lime-flavored beverage that ... its marketing efforts with its product now available through Jet.com. , After 25 ... The effervescent powdered drink is designed to quickly detox the body thereby avoiding alcohol-induced ...
(Date:8/18/2017)... (PRWEB) , ... August 18, 2017 , ... “Our Mountains ... potent tale of a couple that grew stronger together through the faith they shared ... Faith Through Trials” is the creation of published author, Barbara J. Corcoran, a retired ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Beyond Our Imaginations: ... life. “Beyond Our Imaginations: The Infinite God” is the creation of published author, Mark ... the country. , Lawrence shares, “The problem with becoming a greater man of God ...
(Date:8/18/2017)... , ... August 18, 2017 , ... “Kingdom Mandate for ... the Kingdom. “Kingdom Mandate for Kingdom Builders” is the creation of published author, ... moved to Eastern Europe as a missionary in 1983. He spent three decades ...
Breaking Medicine News(10 mins):
(Date:8/7/2017)... 7, 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s ... ended June 30, 2017.  All comparisons, unless otherwise noted, are ... Second Quarter 2017 Highlights include: ... million, an increase of 3.5% Total prescriptions ... margin of 7.5% versus 7.6% Gross ...
(Date:8/4/2017)... 2017 The search for test results that ... consult has long been the goal of healthcare providers ... of the largest meeting of lab professionals and IVD ... research firm Kalorama Information.  The firm said scores of ... related supplies and software were at the American Association ...
(Date:8/3/2017)...  Opioid addiction and other drugs of abuse, blood ... threatening outcomes, were problems taken on directly as laboratory ... support them, met this week. This according to Kalorama ... of abuse, procalcitonin and acute kidney injury were key ... meeting in San Diego, CA. ...
Breaking Medicine Technology: